Replies to post #2142 on Zomedica Corp (ZOM)

[reverse_long]

QUOTES FROM THE FILING OF THE OFFERING:


If you purchase common shares in this offering, you will experience dilution to the extent of the difference between the public offering price per common share in this offering and our pro forma as adjusted net tangible book value per share immediately after this offering . Net tangible book value per share is equal to the amount of our total tangible assets, less total liabilities, divided by the number of outstanding common shares. As of September 30, 2020 our historical net tangible book value was approximately $53.0 million, or approximately $0.094 per share.



After giving effect to the Warrant Exercises, our pro forma tangible net book value as of September 30, 2020 would have been approximately $97.5 million, or approximately $0.116 per common share, an increase of approximately $0.022 per common share.



After giving effect to the sale by us of common shares and after deducting underwriting discounts and commissions and estimated offering expenses payable by us, our pro forma as adjusted net tangible book value as of September 30, 2020 would have been approximately $ million, or approximately $ per share. This represents an immediate increase in pro forma as adjusted net tangible book value of $ per common share to existing shareholders and an immediate dilution of approximately $ per common share to new investors purchasing common shares in this offering. The following table illustrates this per share dilution"